Press "Enter" to skip to content

New patent expiration for APIL drug NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Annual Drug Patent Expirations for NORETHINDRONE+AND+ETHINYL+ESTRADIOL+AND+FERROUS+FUMARATE
Annual Drug Patent Expirations for NORETHINDRONE+AND+ETHINYL+ESTRADIOL+AND+FERROUS+FUMARATE

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Accord Hlthcare, Amneal Pharms, Apil, Barr, Lupin Ltd, and Mylan Labs Ltd and, and is included in seven NDAs. It is available from five suppliers. There is one patent protecting this drug.

Drug patent litigation for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
Do NOT follow this link or you will be banned from the site!